These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 562530)

  • 1. Immunological defects in healthy twin siblings to patients with Hodgkin's disease.
    Björkholm M; Holm G; De Faire U; Mellsted H
    Scand J Haematol; 1977 Oct; 19(4):396-404. PubMed ID: 562530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic profile of patients with cured Hodgkin's disease.
    Bjorkholm M; Holm G; Mellstedt H
    Scand J Haematol; 1977 May; 18(5):361-8. PubMed ID: 141726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune deficiency in family members of patients with Hodgkin's disease.
    Merk K; Björkholm M; Tullgren O; Mellstedt H; Holm G
    Cancer; 1990 Nov; 66(9):1938-43. PubMed ID: 2224790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological family studies in Hodgkin's disease. Is the immunodeficiency horizontally transmitted?
    Björkholm M; Holm G; Mellstedt H
    Scand J Haematol; 1978 Apr; 20(4):297-305. PubMed ID: 653309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte abnormalities in untreated patients with Hodgkin's disease.
    Holm G; Mellstedt H; Björkholm M; Johansson B; Killander D; Sundblad R; Söderberg G
    Cancer; 1976 Feb; 37(2):751-62. PubMed ID: 1082795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.
    Fuks Z; Strober S; Bobrove AM; Sasazuki T; McMichael A; Kaplan HS
    J Clin Invest; 1976 Oct; 58(4):803-14. PubMed ID: 135001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of HL-A antigen phenotypes and lymphocyte abnormalities in Hodgkin's disease.
    Björkholm M; Holm G; Johansson B; Mellstedt H; Möller E
    Tissue Antigens; 1975 Oct; 6(4):247-56. PubMed ID: 1081776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPLEEN/PATHOL.
    Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
    Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term influence of splenectomy on immune functions in patients with Hodgkin's disease.
    Björkholm M; Askergren J; Holm G; Mellstedt H
    Scand J Haematol; 1980 Jan; 24(1):87-94. PubMed ID: 6966069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
    Björkholm M; Holm G; Askergren J; Mellstedt H
    Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of immunocompetence in Hodgkin's disease.
    Faguet GB
    J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 15. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease.
    Mack TM; Cozen W; Shibata DK; Weiss LM; Nathwani BN; Hernandez AM; Taylor CR; Hamilton AS; Deapen DM; Rappaport EB
    N Engl J Med; 1995 Feb; 332(7):413-8. PubMed ID: 7824015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte function in untreated Hodgkin's disease: an important predictor of prognosis.
    Wedelin C; Björkholm M; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Br J Cancer; 1982 Jan; 45(1):70-9. PubMed ID: 6977367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte response to pokeweed mitogen in Hodgkin's disease.
    Cohnen G; König E; Augener W; Brittinger G
    Biomedicine; 1973 Jun; 19(6):239-43. PubMed ID: 4752298
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunodeficiency and prognosis in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H; Johansson B
    Acta Med Scand; 1975 Oct; 198(4):275-9. PubMed ID: 1081328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocytotoxic serum factors and lymphocyte functions in untreated Hodgkin's disease.
    Björkholm M; Wedelin C; Holm G; Ericsson H; Nilsson P; Mellstedt H
    Cancer; 1982 Nov; 50(10):2044-8. PubMed ID: 7127249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis.
    van Rijswijk RE; de Meijer A; Sybesma JP; Kater L
    Cancer; 1986 Apr; 57(8):1489-96. PubMed ID: 2936444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.